Home MedAlliance

MedAlliance

First Sirolimus DEB Patient Enrolled in Japanese SELUTION SLR™ Study

The SELUTION SLR™ Study involves up to 132 patients across a number of centres in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of lesions of superficial femoral arteries and/or popliteal arteries.

World’s First FDA IDE Coronary Patient Treated With a DEB

The objectives of this prospective, randomized, single-blind multicenter study are to demonstrate the safety and efficacy o SELUTION SLR™ 014 DEB n the treatment of ISR with either drug-eluting or bare-metal stents. The study will support the submission for FDA approval.